Stocks and InvestingStocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Salveen Richter Maintained (ATRA) at Strong Sell with Decreased Target to $100 on, May 24th, 2022


Published on 2024-10-27 21:16:43 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Sell with Decreased Target from $125 to $100 on, May 24th, 2022.

Salveen has made no other calls on ATRA in the last 4 months.



There are 3 other peers that have a rating on ATRA. Out of the 3 peers that are also analyzing ATRA, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yigal Nochomovitz of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $200 on, Tuesday, May 10th, 2022


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $725 on, Monday, May 23rd, 2022
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $550 on, Monday, March 28th, 2022